Treace Medical Concepts Statistics
Share Statistics
Treace Medical Concepts has 62.91M
shares outstanding. The number of shares has increased by 0.98%
in one year.
| Shares Outstanding | 62.91M |
| Shares Change (YoY) | 0.98% |
| Shares Change (QoQ) | 0.52% |
| Owned by Institutions (%) | 59.95% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 600 |
| FTD / Avg. Volume | 0.13% |
Short Selling Information
The latest short interest is 2.43M, so 3.86% of the outstanding
shares have been sold short.
| Short Interest | 2.43M |
| Short % of Shares Out | 3.86% |
| Short % of Float | 5.1% |
| Short Ratio (days to cover) | 6.42 |
Valuation Ratios
The PE ratio is -8.29 and the forward
PE ratio is -10.04.
Treace Medical Concepts's PEG ratio is
-0.75.
| PE Ratio | -8.29 |
| Forward PE | -10.04 |
| PS Ratio | 2.21 |
| Forward PS | 1.3 |
| PB Ratio | 4.09 |
| P/FCF Ratio | -9.48 |
| PEG Ratio | -0.75 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Treace Medical Concepts.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.62,
with a Debt / Equity ratio of 0.62.
| Current Ratio | 4.62 |
| Quick Ratio | 3.5 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | -1.66 |
| Debt / FCF | -1.43 |
| Interest Coverage | -10.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $438,903.56 |
| Profits Per Employee | $-116,861.64 |
| Employee Count | 477 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 1.05 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 13.11% in the
last 52 weeks. The beta is 0.8, so Treace Medical Concepts's
price volatility has been higher than the market average.
| Beta | 0.8 |
| 52-Week Price Change | 13.11% |
| 50-Day Moving Average | 7.57 |
| 200-Day Moving Average | 7.27 |
| Relative Strength Index (RSI) | 41.76 |
| Average Volume (20 Days) | 455,213 |
Income Statement
In the last 12 months, Treace Medical Concepts had revenue of 209.36M
and earned -55.74M
in profits. Earnings per share was -0.9.
| Revenue | 209.36M |
| Gross Profit | 168.26M |
| Operating Income | -55.69M |
| Net Income | -55.74M |
| EBITDA | -42.07M |
| EBIT | -50.49M |
| Earnings Per Share (EPS) | -0.9 |
Full Income StatementBalance Sheet
The company has 11.35M in cash and 69.65M in
debt, giving a net cash position of -58.3M.
| Cash & Cash Equivalents | 11.35M |
| Total Debt | 69.65M |
| Net Cash | -58.3M |
| Retained Earnings | -189.99M |
| Total Assets | 205.85M |
| Working Capital | 116.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -37.17M
and capital expenditures -11.59M, giving a free cash flow of -48.76M.
| Operating Cash Flow | -37.17M |
| Capital Expenditures | -11.59M |
| Free Cash Flow | -48.76M |
| FCF Per Share | -0.79 |
Full Cash Flow StatementMargins
Gross margin is 80.37%, with operating and profit margins of -26.6% and -26.63%.
| Gross Margin | 80.37% |
| Operating Margin | -26.6% |
| Pretax Margin | -26.63% |
| Profit Margin | -26.63% |
| EBITDA Margin | -20.09% |
| EBIT Margin | -26.6% |
| FCF Margin | -23.29% |
